Laryngeal papillomatosis: Clinical Trials

6 trials for Laryngeal papillomatosis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 2 recruiting, 1 terminated, 1 unknown. 3 Phase 2, 1 Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 23Recruiting 1, Terminated 1, Unknown 1
Phase 11Recruiting 1
Phase 31Completed 1

Follow Laryngeal papillomatosis: new trials by email Literature Review of Laryngeal papillomatosis trials Research Report on Laryngeal papillomatosis

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Clinical Study of Curcumin in Preventing Postoperative Adhesion of Bilateral Vocal Cords
Curcumin, Mitomycin-C - Glottic Web of Larynx, Laryngeal Stenosis
Phase 1 / Phase 2RecruitingEye & ENT Hospital of Fudan University1002023-05-052023-05-06
Bevacizumab Versus Cidofovir for the Treatment of Recurrent Respiratory Papillomatosis
Bevacizumab, Cidofovir, Placebo - Recurrent Respiratory Papillomatosis
Phase 2UnknownCentro de Investigación en. Enfermedades Infecciosas, Mexico362014-12-012016-07-26
Effect of Vaccination in Patients With Recurrent Respiratory Papillomatosis
Silgard - Squamous Papilloma of the Larynx
Phase 3CompletedRuth Tachezy, PhD.512011-10-012019-01-09
Human Papillomatosis Genotyping of Children in Thailand
biopsy - Recurrent Laryngeal Papillomatosis, Human Papilloma Virus
CompletedQueen Sirikit National Institute of Child Health152011-03-012014-02-17
Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
Rare Disorders, Undiagnosed Disorders
RecruitingSanford Health200002010-07-012025-05-29
Celebrex (Celecoxib) Treatment of Laryngeal Papilloma
Celebrex, PDL, CO2 laser or microsurgery - Laryngeal Papilloma
Phase 2TerminatedBoston University102005-05-012012-08-31

Narrower conditions

Recurrent respiratory papillomatosis (3)  ·  3-Methylglutaconic Aciduria, Type V (1)  ·  Achalasia Addisonianism Alacrimia syndrome (1)  ·  Acrodysostosis (1)  ·  Addison Disease (1)  ·  Alagille Syndrome (1)  ·  Alstrom Syndrome (1)  ·  Amnesia, Transient Global (1)  ·  Aniridia (1)  ·  Aniridia and Absent Patella (1)  ·  Aniridia, Partial, with Unilateral Renal Agenesis and Psychomotor Retardation (1)  ·  Ataxia (1)  ·  Ataxia Neuropathy Spectrum (1)  ·  Ataxia Telangiectasia (1)

Broader conditions

Congenital Abnormalities (2)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2)  ·  Neoplasms (2)  ·  Neoplasms by Histologic Type (2)  ·  Otorhinolaryngologic Diseases (2)  ·  Abnormalities, Multiple (1)  ·  Adrenal Gland Diseases (1)  ·  Adrenal Insufficiency (1)  ·  Amino Acid Metabolism, Inborn Errors (1)  ·  Amino Acid Transport Disorders, Inborn (1)  ·  Amnesia (1)  ·  Anemia (1)  ·  Anemia, Hemolytic (1)  ·  Aortic Stenosis, Supravalvular (1)  ·  Aortic Valve Disease (1)

Interventions

Bevacizumab (1)  ·  Biopsy (1)  ·  Celecoxib (1)  ·  Cidofovir (1)  ·  Curcumin (1)  ·  Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 (1)  ·  Laser Therapy (1)  ·  Lasers, Gas (1)  ·  Microsurgery (1)  ·  Mitomycin (1)

Sponsors

Boston University (1)  ·  Centro de Investigación en. Enfermedades Infecciosas, Mexico (1)  ·  Eye & ENT Hospital of Fudan University (1)  ·  Queen Sirikit National Institute of Child Health (1)  ·  Ruth Tachezy, PhD. (1)  ·  Sanford Health (1)

Countries

United States (2)  ·  Australia (1)  ·  China (1)  ·  Czechia (1)  ·  Mexico (1)  ·  Thailand (1)

Top investigators

Pavinee Intakorn, MD (1)  ·  Ruth Tachezy, PhD. (1)  ·  Wang Zhi, M.D (1)

Results publications

PMID 35397828, PMID 35653138

NIH funding

R01DC006617 (1)